<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head><title>R: Breast Cancer multi omics data from TCGA</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link rel="stylesheet" type="text/css" href="R.css" />
</head><body><div class="container">

<table width="100%" summary="page for breast.TCGA {mixOmics}"><tr><td>breast.TCGA {mixOmics}</td><td style="text-align: right;">R Documentation</td></tr></table>

<h2>Breast Cancer multi omics data from TCGA</h2>

<h3>Description</h3>

<p>This data set is a small subset of the full data set from The Cancer Genome
Atlas that can be analysed with the DIABLO framework. It contains the
expression or abundance of three matching omics data sets: mRNA, miRNA and
proteomics for 150 breast cancer samples (Basal, Her2, Luminal A) in the
training set, and 70 samples in the test set. The test set is missing the
proteomics data set.
</p>


<h3>Usage</h3>

<pre>
data(breast.TCGA)
</pre>


<h3>Format</h3>

<p>A list containing two data sets, <code>data.train</code> and
<code>data.test</code> which both include: </p>
 <dl>
<dt>list(&quot;miRNA&quot;)</dt><dd><p>data
frame with 150 (70) rows and 184 columns in the training (test) data set.
The expression levels of 184 miRNA.</p>
</dd> <dt>list(&quot;mRNA&quot;)</dt><dd><p>data frame with 150
(70) rows and 520 columns in the training (test) data set. The expression
levels of 200 mRNA.</p>
</dd> <dt>list(&quot;protein&quot;)</dt><dd><p>data frame with 150 (70) rows
and 142 columns in the training data set only. The abundance of 142
proteins.</p>
</dd> <dt>list(&quot;subtype&quot;)</dt><dd><p>a factor indicating the brerast cancer
subtypes in the training (length of 150) and test (length of 70) sets. </p>
</dd> </dl>



<h3>Details</h3>

<p>The data come from The Cancer Genome Atlas (TCGA,
http://cancergenome.nih.gov/). We divided the data into a training
(discovery) and test (validation) set. The protein dataset which had a
limited number of subjects available was used to allocate subjects into the
training set only, while the tes set included all remaining subject. Each
data set was normalised and pre-processed. For illustrative purposes we
drastically filtered the data here.
</p>


<h3>Value</h3>

<p>none
</p>


<h3>Source</h3>

<p>The raw data were downloaded from
<a href="http://cancergenome.nih.gov/">http://cancergenome.nih.gov/</a>. The normalised and filtered data we
analysed with DIABLO are available on <a href="www.mixOmics.org/mixDIABLO">www.mixOmics.org/mixDIABLO</a>
</p>


<h3>References</h3>

<p>Singh A., Shannon C., Gautier B., Rohart F., Vacher M., Tebbutt S.
and Lê Cao K.A. (2019), DIABLO: an integrative approach for identifying key 
molecular drivers from multi-omics assays, Bioinformatics, 
Volume 35, Issue 17, 1 September 2019, Pages 3055–3062.
</p>

<hr /><div style="text-align: center;">[Package <em>mixOmics</em> version 6.18.1 <a href="00Index.html">Index</a>]</div>
</div></body></html>
